SecBot SecBot

IRIX

IRIDEX CORP
Nasdaq· Electromedical & Electrotherapeutic Apparatus· Inc. DE· CIK 0001006045 Healthcare & Medical Devices
$0.7450 −0.00 (−0.67%)
Oct 27 4:00 PM ET · prev $0.7500
Market cap
$13.1M
Nano cap
Median target
$2.75
+269% · range $2.75–2.75
Next earnings
Nov 17
in 21 days · EPS est. −$0.04
1 year
−29.7%
from $1.06 · Oct 27
30 days
+20.2%
from $0.6200
52-week range
$0.6100–1.56
−52% from high · low Sep 16
Avg volume 20D
1.09M
Oct 7 spike 19.76M
Short interest
🔒 Subscribers only
Insider net
+$379.7K
2 buyers · 0 sellers · since Dec 30
New fund stakes
0
Q2 2026 13F · 0 exits
Filing reports
5
analyzed by SecBot
SecBot read BEARISH 2 reports · 90 days
Balance 2 bearish · 0 bullish oldest → newest, height = score
Avg score ·High conf. 2/2 ·Next Earnings date, Nov 17, 2026
Strongest BEARISH Iridex reported Q2 2026 revenue of $12.6M, a 7% YoY decline from $13.6M, missing the $13.6M consensus. EPS…
All reports →

Price

Daily candles with volume. Pins mark insider trades, rating changes, 13F stakes, reports, catalysts and short-interest jumps.

  • B Jan 7 to Jan 8 2 days of insider buys: $25.6K by 1 insider, avg $1.20
  • B Jan 23 to Mar 30 22 days of insider buys: $314.7K by 2 insiders, avg $1.41
  • B May 26 1 insider buy $5.0K at $1.00
  • B Jun 3 to Jun 12 5 days of insider buys: $11.4K by 1 insider, avg $1.14
  • R Aug 18 Iridex reported Q2 2026 revenue of $12.6M, a 7% YoY decline from $13…
  • B Aug 24 1 insider buy $5.0K at $0.7497
  • X Aug 31 Short interest jumps 291.8% to 148.3K
  • B Sep 10 to Sep 16 3 days of insider buys: $10.0K by 1 insider, avg $0.6497

Signal stack

Where each data set points today.

  • InsidersBULLISH

    2 insiders bought $379.7K at an average $1.31. No open-market sales. Price is 43% below their cost.

  • InstitutionsMIXED

    Q2 2026: 1 added (0 new), 2 trimmed or exited.

  • EstimatesFALLING

    Current-quarter EPS estimate −$0.020 → −$0.040 over 90 days. 0 up, 1 down in 30 days.

  • TrendUPTREND

    3% above its 50-day average.

Who's buying

13F· Q2 2026
0
new positions
0
exits
FundMoveSharesValue
CITADEL ADVISORS LLCADD98,950$113.3K
UNITED CAPITAL FINANCIAL ADVISORS, LLCTRIM35,529$40.7K
SIMPLEX TRADING, LLCTRIM112$128.00
SIMPLEX TRADING, LLCTRIM160$161.00
JANE STREET GROUP, LLCADD31,758$36.2K
BANK OF AMERICA CORP /DE/NEAR_EXIT127$144.00
CITADEL ADVISORS LLCDOUBLED109,473$125.9K
BANK OF AMERICA CORP /DE/DOUBLED622$709.00

Quarterly 13F filings are due 45 days after each quarter ends.

The Street

last action May 2024
12-month targets · 1 analysts

Price is below the lowest target. Median implies +269%.Targets as of Oct 27, 2026.

Recent actions
DateFirmActionRating
May 15, 2024Stifel
MAINTAIN
MAINTAINHold
Aug 26, 2022Stifel
DOWNGRADE
DOWNGRADEHold
May 12, 2021Roth Capital
MAINTAIN
MAINTAINBuy
Mar 3, 2021Roth Capital
MAINTAIN
MAINTAINBuy
Jan 13, 2021Roth Capital
MAINTAIN
MAINTAINBuy
May 12, 2020Stifel
MAINTAIN
MAINTAINBuy

Insider ledger

Form 4
$379.7K
bought · 2 insiders
$0
sold · 0 insiders
−43.3%
vs their $1.31 cost
DateInsiderTypeValue
Oct 2, 2026
Novel Inspiration International Co., Ltd.
10%+ Owner
OTHER146,313 sh
Oct 1, 2026
Mercer Patrick
President and CEO
TAX W/H$15.1K
Sep 16, 2026
Dizon Romeo R
Chief Financial Officer
BUY$5.0K
Sep 14, 2026
Dizon Romeo R
Chief Financial Officer
BUY$1.5K
Sep 10, 2026
Dizon Romeo R
Chief Financial Officer
BUY$3.5K
Aug 24, 2026
Dizon Romeo R
Chief Financial Officer
BUY$973.44
Aug 24, 2026
Dizon Romeo R
Chief Financial Officer
BUY$4.0K
Jul 10, 2026
Mercer Patrick
President and CEO
AWARD100,000 sh

Earnings setup

Estimates
Nov 17
reports in 21 days
−$0.04
EPS estimate, this quarter
−100%
estimate change, 90 days
0↑ 1↓
revisions, 30 days
Current-quarter EPS estimate
PeriodEPS est.Range30D rev.Revenue
Current Q-$0.04-$0.04–-$0.04-100.0%$12.6M
Next Q$0.02$0.02–$0.02+100.0%$15.5M
Current FY-$0.12-$0.12–-$0.12-140.0%$52.5M
Next FY$0.00$0.00–$0.00-100.0%$56.0M

Short side

FINRA· Oct 15, 2026
🔒 Subscribers only
shares short
Recent activity
The latest filings, insider trades, analyst actions, press and options flow — newest first.
Oct 5, 2026 Other
Iridex Completes Relocation of Manufacturing Facility to San Jose, California
Company Expects to Realize Approximately $600,000 in Annualized Cost Savings Company Expects to Real
Oct 2, 2026 Insider
Novel Inspiration International Co., Ltd. acquired 146,313 shares
10%+ Owner
Oct 1, 2026 Insider
Mercer Patrick surrendered for taxes 23,917 shares
President and CEO @ $0.6320 ($15.1K)
Sep 16, 2026 Insider
Dizon Romeo R bought 7,900 shares
Chief Financial Officer @ $0.6300 ($5.0K)
Aug 18, 2026 SEC
Iridex reported Q2 2026 revenue of $12.6M, a 7% YoY decline from $13.6M, missing the $13.6M consensus. EPS of -$0.07…
8-K — Impact 7/10
Aug 18, 2026 SEC
IRIDEX reported Q2 2026 revenue of $12.6M, down 7% YoY and below the $13.6M consensus, with a GAAP net loss of…
PRESS-RELEASE — Impact 6/10
Jul 16, 2026 SEC
IRIDEX disclosed a governance crisis at its 2026 annual meeting, alleging that its largest stockholder (Novel…
8-K — Impact 7/10
Jun 30, 2026 Inst.
CITADEL ADVISORS LLC — ADD
98,950 shares ($113.3K)
Catalysts
Scheduled dates and disclosed events: earnings, FDA and trial readouts, halts, press releases. Colored dot = impact.
Upcoming
Nov 17, 2026
Earnings date
IRIX Q3 2026 Earnings Scheduled — 2026-11-17
Recent
Oct 5, 2026
Press release
Iridex Completes Relocation of Manufacturing Facility to San Jose, California
Company Expects to Realize Approximately $600,000 in Annualized Cost Savings Company Expects to Realize Approximately $600,000 in Annualized Cost…
Sep 3, 2026
Listing
Listing Status: IRIX — Deficient (was Normal)
IRIDEX Corporation - Common Stock | Nasdaq Financial Status Indicator N → D
Aug 18, 2026
Earnings
Iridex Reports Second Quarter 2026 Financial Results
MOUNTAIN VIEW, Calif., Aug. 18, 2026 (GLOBE NEWSWIRE) -- Iridex Corporation (Nasdaq: IRIX), a worldwide leader providing innovative and versatile…
Aug 18, 2026
Earnings date
IRIX Q2 2026 Earnings Scheduled — 2026-08-18
Aug 6, 2026
Earnings date
IRIX Q2 2026 Earnings Scheduled — 2026-08-06

SecBot reports

5 filings · 3 press releases · 0 bullish · 3 bearish · 2 neutral
All IRIX filing & press-release reports (8)